$MDAI: FDA de novo clearance—here’s the historical next-day playbook
How MDAI has reacted before
| Report | Next-day move |
|---|---|
| May 2026 | -5.1% |
| Mar 2026 | -6.7% |
| Nov 2025 | -7.0% |
| Aug 2025 | -5.2% |
| May 2025 | -8.5% |
| Mar 2025 | -11.7% |
| Nov 2024 | -11.3% |
| Sep 2024 | -2.1% |
Median absolute move 6.8% · higher 0 of 8 · n=8
Spectral AI, Inc. Class A Common Stock ($MDAI) reports it achieved FDA de novo clearance for its Deep View system, with expectations for strong market adoption and revenue growth through 2027.
How $MDAI has reacted to earnings
| Report | Next-day |
|---|---|
| May 2026 | -5.1% |
| Mar 2026 | -6.7% |
| Nov 2025 | -7.0% |
| Aug 2025 | -5.2% |
| May 2025 | -8.5% |
| Mar 2025 | -11.7% |
| Nov 2024 | -11.3% |
| Sep 2024 | -2.1% |
Base rate (n=8):
- Median absolute next-day move: 6.8%
- Higher next day: 0 of 8
- Biggest up: -2.1%
- Biggest down: -11.7%